CRIS Connect: Strength in Numbers – Synergising Discoveries through Clinical Research Networks
Registration
Please register via https://for.sg/crisconnect
Registration closes Mon, 30 Mar 2026.
About the Speakers
Dr David SP Tan
Group Director, Partnership and Innovation, National University Health System (NUHS)
Dr David Tan is a senior consultant medical oncologist at the National University Cancer Institute, Singapore (NCIS) and an Associate Professor in the Department of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore (NUS), and Principal Investigator at the Cancer Science Institute, NUS. His primary clinical and research interests are in gynaecological cancers, precision oncology, and early phase trials (link to publications: https://discovery.nus.edu.sg/4508-shao-peng-david-tan/publications).
Dr Tan is currently the Group Director of Partnerships and Innovation at National University Health Systems (NUHS) and Director of the Research Transformation Office at NUHS. He was the founding President of the Gynecologic Cancer Group Singapore (GCGS), and inaugural President of the Asia-Pacific Gynaecologic Oncology Trials (APGOT) Group.
He currently chairs the APGOT Protocol Review Committee. He is also the past-chair of the Cervical Cancer Research Network (CCRN) of the of the Gynecologic Cancer InterGroup (GCIG) and is a member of the executive board of directors of the GCIG.
Dr Patricia Tay
Head, Clinical Research Networks and Outreach, Singapore Clinical Research Institute (SCRI)
As the Head of Clinical Research Networks and Outreach in Singapore Clinical Research Institute (SCRI), Dr Patricia Tay oversees the development and maintenance of investigator-initiated clinical research networks (CRNs). This involves ensuring CRNs members can collaborate effectively and enabling smooth-sailing of clinical research trials. Dr Tay completed her PhD in anti-cancer research at the National University of Singapore.
With over 14 years of experience spanning healthcare outreach and academic research, she has had the opportunity to work across different disease areas, facilitating outputs such as the development of treatment guidelines in Singapore and the region. She is passionate about advancing clinical research to impact patient care through coordinated efforts.